Semaglutide in the ESSENCE Trial: A Breakthrough for Liver Disease Treatment?
Liver disease, especially metabolic dysfunction-associated steatohepatitis (MASH), has long been a silent threat, affecting millions of people globally. Often progressing…
Tag: Semaglutide
Weight-Loss Jabs Could Slash Cancer Risk by 50%: A “Transformational” Breakthrough
Key Findings at a Glance The Study: How Weight-Loss Drugs Stack Up Against Surgery A landmark Israeli study (presented at the European Congress…
Tirzepatide vs. Semaglutide for Obesity: Which Weight-Loss Drug Works Better?
New SURMOUNT-5 Trial Results (2025) Key Takeaways ✅ Tirzepatide (Zepbound) led to significantly greater weight loss than semaglutide (Wegovy). Background: The…
Frequent Asked Questions about Obesity
Obesity is one of the most misunderstood health crises of our time. Below, we tackle the most pressing questions—backed by…
The Paradox of Obesity Drugs: How Opposite Approaches Both Lead to Weight Loss
A Scientific Mystery Solved In a breakthrough that defies conventional logic, researchers have discovered that two completely opposite drug strategies—stimulating and blocking the same…
List of Oral GLP-1 Drugs: 2025 Update
With GLP-1 receptor agonists (GLP-1 RAs) gaining popularity for managing type 2 diabetes and promoting weight loss, many people are…
WHO Supports Worldwide Use of Adult Weight-Loss Drugs, Highlights Cost Hurdle
In a groundbreaking move, the World Health Organization (WHO) is preparing to recommend the use of weight-loss medications like Wegovy…